| |
Viral hepatitis (group II) (n = 146)
|
NAFLD (group III) (n = 39)
|
χ2
|
p
|
|---|
|
No.
|
%
|
No.
|
%
|
|---|
|
TCA
|
|
≤ 0.001
|
67
|
45.9
|
36
|
92.3
|
26.872*
|
< 0.001*
|
|
> 0.001
|
79
|
54.1
|
3
|
7.7
|
|
TCDCA
|
|
≤ 0.02
|
57
|
39.0
|
22
|
56.4
|
3.795
|
0.051
|
|
> 0.02
|
89
|
61.0
|
17
|
43.6
|
|
TUDCA
|
|
≤ 0
|
59
|
40.4
|
17
|
43.6
|
0.128
|
0.720
|
|
> 0
|
87
|
59.6
|
22
|
56.4
|
|
TLCA
|
|
≤ 0
|
49
|
33.6
|
17
|
43.6
|
1.349
|
0.245
|
|
> 0
|
97
|
66.4
|
22
|
56.4
|
|
GCA
|
|
≤ 0.35
|
71
|
48.6
|
25
|
64.1
|
2.952
|
0.086
|
|
> 0.35
|
57
|
51.4
|
14
|
35.9
|
|
GCDCA
|
|
≤ 1.1
|
73
|
50.0
|
30
|
76.9
|
9.040*
|
0.003*
|
|
> 1.1
|
73
|
50.0
|
9
|
23.1
|
|
UDCA
|
|
≤ 0
|
36
|
24.7
|
20
|
51.3
|
10.337*
|
0.001*
|
|
> 0
|
110
|
75.3
|
19
|
48.7
|
|
DCA
|
|
≤ 0.04
|
27
|
18.5
|
17
|
43.6
|
10.694*
|
0.001*
|
|
> 0.04
|
119
|
81.5
|
22
|
56.4
|
|
LCA
|
|
≤ 0
|
61
|
41.8
|
36
|
92.3
|
31.505*
|
< 0.001*
|
|
> 0
|
85
|
58.2
|
3
|
7.7
|
- χ2 Chi-square test, p value for comparing between the studied groups
- CDCA Chenodeoxycholic acid,TCA taurocholic acid, TCDCA taurochenodeoxycholic acid, TUDCA taurodeoxycholic acid, TLCA taurolithocholic acid, GCA glycholic acid, GCDCA, UDCA ursodeoxycholic acid, DCA deoxycholic acid, LCA lithocholic acid
- *Statistically significant at p ≤ 0.05
